Gastric cancer stage IV – Diagnostics

Go back

Understanding how stage IV gastric cancer is diagnosed is crucial for patients and their families navigating this challenging journey. While the diagnosis of advanced stomach cancer can feel overwhelming, knowing what tests and procedures are involved helps patients prepare for what lies ahead and makes the complex medical process feel more manageable.

Introduction: When Should You Seek Diagnostic Testing?

Stage IV gastric cancer, also known as advanced or metastatic stomach cancer, represents a situation where cancer cells have traveled beyond the stomach to reach distant parts of the body. By the time cancer reaches this stage, it has usually spread through tissue, the bloodstream, or the lymphatic system to organs such as the liver, lungs, or distant lymph nodes, or to the tissue lining the abdominal cavity called the peritoneum[1][4].

Diagnosing stomach cancer at an advanced stage can be particularly challenging because symptoms often appear late in the disease’s progression. Many people with early-stage stomach cancer experience no symptoms at all, which is why the disease is frequently discovered only after it has already spread[6].

You should consider seeking medical attention if you experience persistent symptoms that interfere with your daily life. In the early stages of stomach cancer, you might notice indigestion, a bloated feeling after eating, mild nausea, loss of appetite, or heartburn. These symptoms are common and can be caused by many conditions, but if they don’t go away, it’s worth discussing them with your doctor[6].

As stomach cancer progresses to more advanced stages, additional warning signs may appear. These include blood in your stool, vomiting, unexplained weight loss, stomach pain, yellowing of the eyes and skin (a condition called jaundice), build-up of fluid in the abdomen known as ascites, and trouble swallowing[6]. Any of these symptoms warrants prompt medical evaluation.

⚠️ Important
It’s important to remember that having these symptoms does not automatically mean you have stomach cancer. Many other, less serious conditions can cause similar problems. However, if you’re experiencing any of these symptoms persistently, checking with your doctor is the safest course of action. Early investigation can make a significant difference in outcomes.

Classic Diagnostic Methods for Stage IV Gastric Cancer

When doctors suspect stomach cancer, they use a combination of physical examinations, laboratory tests, and imaging procedures to confirm the diagnosis and determine how far the cancer has spread. Understanding these methods can help you feel more prepared for the diagnostic process.

Physical Examination and Medical History

Your diagnostic journey typically begins with a thorough physical examination and a detailed review of your medical history. During this exam, your doctor will check for general signs of health and look for anything unusual, such as lumps or swelling. They’ll also ask about your health habits, past illnesses, and any treatments you’ve received. This information helps your doctor understand your overall health picture and identify potential risk factors[6].

Blood Chemistry Studies

Blood tests play an important role in diagnosing stomach cancer. In a blood chemistry study, a sample of your blood is analyzed to measure the amounts of certain substances released into the blood by your organs and tissues. Unusual levels of these substances can be a sign that something isn’t working properly. For example, doctors may check levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9), which are tumor markers that can be elevated in people with stomach cancer[6][8].

Endoscopy and Gastroscopy

One of the most important tests for diagnosing stomach cancer is an endoscopy, sometimes called a gastroscopy when it specifically examines the stomach. During this procedure, your doctor inserts a thin, flexible tube with a light and tiny camera on the end down your throat and into your stomach. This allows them to look directly at the inside of your esophagus and stomach to check for abnormal areas[3].

If the doctor sees something suspicious during the endoscopy, they can take a small tissue sample, called a biopsy, right then and there. This tissue is then examined under a microscope by a specialist to determine if cancer cells are present and what type they are. The biopsy is crucial because it provides a definitive diagnosis of whether cancer is present[3].

Imaging Tests to Determine Cancer Spread

Once stomach cancer is confirmed, doctors need to understand how far it has spread. This is where various imaging tests become essential. These tests create detailed pictures of the inside of your body and help doctors see if cancer has reached other organs or tissues.

Computed Tomography (CT) scans are commonly used to examine the abdomen and look for signs of cancer spread. A CT scan uses X-rays taken from different angles and combines them to create cross-sectional images of your body. Before the scan, you might receive a contrast material by mouth or injection to help certain areas show up more clearly[1].

Positron Emission Tomography (PET) scans are another imaging tool that can help identify cancer cells throughout the body. During a PET scan, a small amount of radioactive sugar is injected into your vein. Cancer cells absorb more of this sugar than normal cells do, so they show up brighter on the scan[1].

Other imaging tests that might be used include chest X-rays to check if cancer has spread to the lungs, and various types of ultrasound examinations. Each of these tests provides different information that helps doctors understand the full extent of the disease[1].

Understanding Staging Systems

After all the diagnostic tests are completed, doctors use a staging system to describe how advanced the cancer is. The most common system is called the TNM staging system. In this system, “T” describes the size of the primary tumor and how far it has grown into the stomach wall, “N” indicates whether the cancer has spread to nearby lymph nodes, and “M” shows whether the cancer has spread to distant parts of the body[1][2].

For stage IV stomach cancer in the clinical staging system, there are two subcategories. Stage 4A means the cancer has grown through the stomach wall into nearby organs or tissues and might have spread to nearby lymph nodes, but hasn’t reached distant body parts. This is sometimes called locally advanced cancer. Stage 4B means the cancer has spread to distant body parts, which is referred to as advanced, metastatic, or secondary cancer[1].

It’s worth knowing that there are different ways doctors determine your stage. Clinical staging happens before treatment when the doctor examines you and reviews test and scan results. Pathological staging occurs if you have surgery, when the doctor examines tissue removed during the operation. Sometimes these two types of staging can give slightly different results, and pathological staging is generally considered more precise[1].

Diagnostics for Clinical Trial Qualification

If you’re considering participating in a clinical trial, you may need to undergo additional diagnostic tests beyond those used for standard diagnosis. Clinical trials are research studies that test new treatments or combinations of treatments, and they have specific requirements for who can participate.

Molecular and Genetic Testing

Modern cancer treatment increasingly relies on understanding the specific genetic characteristics of your tumor. For patients with advanced gastric cancer, doctors now routinely perform tests to look for specific genetic markers that can guide treatment decisions. This approach is sometimes called precision medicine or personalized medicine[10].

One important test checks whether your cancer produces too much of a protein called HER2. Stomach cancers that make too much of this protein are called HER2-positive, and they can be treated with specific targeted drugs. About 20% of people with stomach cancer have HER2-positive tumors[7][10].

Doctors may also test for other markers like PD-1 and various genetic mutations that could make you eligible for specific targeted therapies or immunotherapy treatments. These tests are performed on the tissue sample taken during your biopsy[10].

Performance Status Assessment

Clinical trials often require participants to have a certain level of physical functioning, which doctors assess using something called performance status (PS). This is a measure of how well you can carry out your daily activities and how much the cancer affects your overall ability to function. Your performance status helps determine whether you’re strong enough to participate in a particular trial and tolerate the experimental treatment being studied[8].

Baseline Testing Before Trial Entry

Before you can enter a clinical trial, you’ll typically need a comprehensive set of baseline tests. These establish your starting point so researchers can measure how the experimental treatment affects your condition over time. These baseline tests might include detailed blood work, repeat imaging scans, heart function tests, and assessments of how well your kidneys and liver are working.

The specific tests required vary depending on the trial, but having these baseline measurements is essential for determining whether you’re eligible for the study and for tracking your response to treatment safely throughout the trial period.

⚠️ Important
Not everyone with stage IV gastric cancer will be eligible for clinical trials, and that’s completely normal. Eligibility depends on many factors including the specific characteristics of your cancer, your overall health, previous treatments you’ve received, and the specific requirements of available trials. Your oncologist can discuss whether participating in a clinical trial might be a good option for you.

Monitoring During Treatment

Once diagnosis is complete and treatment begins, regular monitoring becomes an important part of your care. For patients receiving chemotherapy, scans are typically done every two to three months to check how well the treatment is working. These repeat imaging tests show whether tumors are shrinking, staying the same size, or growing. Your doctor uses this information to decide whether to continue your current treatment or try a different approach[4].

You’ll also have frequent appointments with your medical team, often every two weeks during active treatment. These visits give your doctors a chance to check for side effects, adjust medications if needed, and answer any questions you might have. Regular blood tests help monitor your overall health and ensure your body is handling the treatment well[4].

Prognosis and Survival Rate

Prognosis

The outlook for stage IV gastric cancer depends on many different factors that work together to influence how the disease progresses. Your individual prognosis is affected by specific characteristics of the cancer itself, your overall health, and how well you respond to treatment. Important factors that doctors consider include your age, your performance status (how well you can carry out daily activities), the location of the primary tumor in your stomach, the type of cancer cells, levels of tumor markers like CEA and CA19-9, and how far the cancer has spread[8].

Stage IV gastric cancer is considered advanced disease, and while cure is rarely achieved at this stage, treatment can help control the cancer’s growth and maintain quality of life. The treatment goal shifts from trying to eliminate the cancer completely to prolonging life and managing symptoms effectively. Some patients respond very well to treatment and can live for extended periods with good quality of life, while outcomes vary significantly from person to person[3][11].

It’s important to understand that while statistics provide general information, they cannot predict exactly what will happen in your individual case. Your doctor knows your specific situation and can give you more personalized information about your outlook. Factors like receiving treatment at a specialized center, having access to newer therapies including targeted drugs and immunotherapy, and having a strong support system can all positively influence outcomes[3].

Survival Rate

Survival statistics for stage IV gastric cancer show that this is a serious diagnosis, but it’s important to remember that these numbers are based on large groups of people and may not reflect the most current treatments available today. According to data from England, around 20 out of 100 people (about 20%) with stage 4 stomach cancer survive for 1 year or more after their diagnosis[1].

Looking at stomach cancer survival more broadly across all stages in the UK, statistics show that about 45 out of every 100 people (45%) survive for 1 year or more, around 20 out of every 100 (around 20%) survive for 5 years or more, and around 15 out of every 100 (around 15%) survive for 10 years or more. These figures represent a mix of all stages, so survival for stage IV specifically would be at the lower end of this range[19].

Previous research from Japan and Korea has shown 5-year survival rates for stage IV patients of 15.3% and 18% respectively, though these studies included various treatment approaches[8]. It’s crucial to understand that survival statistics don’t mean you will only live for that specific time period. Some people live much longer than the average, especially with newer treatments that continue to be developed and with personalized care approaches.

Many factors can affect survival beyond just the stage of cancer, including response to treatment, overall health and fitness, access to specialized care, and the specific characteristics of the tumor. Advances in targeted therapies, immunotherapy, and improved surgical techniques continue to offer hope for better outcomes, and clinical trials may provide access to promising new treatments not yet widely available[12][14].

Ongoing Clinical Trials on Gastric cancer stage IV

  • Study of ivonescimab with chemotherapy combination for first and second-line treatment in patients with advanced or metastatic gastric and gastroesophageal cancer

    Recruiting

    2 1 1 1
    France
  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium France Spain

References

https://www.cancerresearchuk.org/about-cancer/stomach-cancer/stages/stage-4

https://www.cancer.gov/types/stomach/stages

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/diagnosis-treatment/drc-20352443

https://www.healthline.com/health/stomach-cancer-stage-4

https://www.mskcc.org/cancer-care/types/stomach-gastric/diagnosis/stages

https://vicc.org/cancer-info/adult-gastric-cancer

https://cancer.ca/en/cancer-information/cancer-types/stomach/treatment/stage-4-and-recurrent

https://pmc.ncbi.nlm.nih.gov/articles/PMC3723175/

https://cancer.ca/en/cancer-information/cancer-types/stomach/treatment/stage-4-and-recurrent

https://www.cancer.gov/types/stomach/treatment/by-stage

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/diagnosis-treatment/drc-20352443

https://pmc.ncbi.nlm.nih.gov/articles/PMC5653678/

https://www.texasoncology.com/types-of-cancer/gastric-cancer/treatment-of-stage-iv-metastatic-gastric-cancer

https://www.mskcc.org/news/how-checkpoint-inhibitors-for-stage-4-stomach-cancer-worked-for-antonio

https://www.cancerresearchuk.org/about-cancer/stomach-cancer/stages/stage-4

https://www.tfhd.com/cancer-center/resource-center/types-of-cancer/gastric-cancer/treatment-of-stage-iv-metastatic-gastric-cancer/

https://www.healthline.com/health/stomach-cancer-stage-4

https://www.mdanderson.org/cancerwise/-how-i-knew-i-had-stomach-cancer—six-survivors-share-their-symptoms.h00-159697545.html

https://www.cancerresearchuk.org/about-cancer/stomach-cancer/survival

https://health.clevelandclinic.org/coping-with-stomach-cancer-changes

https://cancer.ca/en/cancer-information/cancer-types/stomach/treatment/stage-4-and-recurrent

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/diagnosis-treatment/drc-20352443

https://www.cancercare.org/publications/382-treatment_update_gastric_cancer

https://www.cancer.gov/types/stomach/coping

https://www.healthline.com/health/stomach-cancer-stage-4

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://pmc.ncbi.nlm.nih.gov/articles/PMC6558629/

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

What is the difference between clinical staging and pathological staging?

Clinical staging happens before treatment when your doctor examines you and reviews all your test and scan results to determine the cancer’s stage. Pathological staging occurs after surgery, when the doctor examines the actual tissue removed during the operation. Pathological staging is generally more precise because it’s based on direct examination of the cancer tissue, but not everyone has surgery, so clinical staging may be the only option available. Sometimes these two staging methods can give slightly different results.

Do I need all the diagnostic tests mentioned, or will my doctor choose specific ones?

Your doctor will select which tests are most appropriate for your specific situation based on your symptoms, medical history, and what they find during initial examinations. Not everyone needs every test. The combination of tests used depends on factors like what the initial results show, whether you’ve already had certain tests, and what information is still needed to plan your treatment effectively.

What does HER2-positive stomach cancer mean?

HER2-positive means your stomach cancer produces too much of a protein called HER2. About 20% of stomach cancers are HER2-positive. This information is important because specific targeted drugs can be used to treat HER2-positive cancers. Your doctor tests for HER2 status by examining the tissue taken during your biopsy, and knowing whether your cancer is HER2-positive or HER2-negative helps guide treatment decisions.

How often will I need scans and tests during treatment?

If you’re receiving chemotherapy, you’ll typically have appointments every two weeks, though the exact frequency depends on your treatment plan. Imaging scans to check how well treatment is working are usually done every two to three months. Your doctor uses these regular scans to see if tumors are shrinking or if the treatment approach needs to be adjusted. The frequency of testing may change based on how you’re responding to treatment.

Should I get a second opinion after my diagnosis?

Getting a second opinion is advisable and is a common practice for cancer diagnoses. It’s particularly helpful to seek opinions from specialized centers that frequently treat stomach cancer, as these cancers are relatively rare in some countries. Doctors from specialized centers can often work together with your local doctor as a team to provide you with the best care. A second opinion can confirm your diagnosis, provide additional treatment options, or give you more confidence in the recommended plan.

🎯 Key Takeaways

  • Stage IV gastric cancer means the disease has spread beyond the stomach to distant organs or tissues, requiring comprehensive diagnostic testing to understand the full extent of spread.
  • Endoscopy with biopsy is the gold standard for diagnosing stomach cancer, allowing doctors to directly see inside your stomach and take tissue samples for examination.
  • Multiple imaging tests including CT scans, PET scans, and X-rays work together to create a complete picture of where cancer has spread throughout the body.
  • Genetic testing of your tumor for markers like HER2 and PD-1 is now standard practice and can open doors to targeted therapies and immunotherapy options.
  • Clinical trials may require additional diagnostic tests beyond standard care, but can provide access to promising new treatments not yet widely available.
  • Regular monitoring during treatment, typically every 2-3 months with scans, helps doctors track whether treatment is working and adjust the plan if needed.
  • While stage IV gastric cancer is serious with around 20% one-year survival, individual outcomes vary greatly and newer treatments continue to improve possibilities.
  • Seeking care at specialized centers and getting a second opinion can provide access to more treatment options and expertise in managing advanced stomach cancer.